Found 333 matching trials
A Study of XZB-0004 in Patients With Solid Tumors PHASE1 XZB-0004 is a novel and potent small molecule inhibitor of receptor tyrosin...
Show More Location
Shanghai Pulmonary Hospital
Learn More & Join Trial
Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC PHASE2 This is a single-center, single-arm, phase II clinical study to evaluate th...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Targeted Therapy and a PD-1 Inhibitor in Patients With Postoperative Hepatocellular Carcinoma and Microvascular Invasion PHASE4 A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Sa...
Show More Location
The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma PHASE2 The purpose of this study is to explore the efficacy and safety of compare ...
Show More Location
Fujian Cancer Hospital
Learn More & Join Trial
Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE) PHASE2 This is an investigator-initiated, single-arm, exploratory clinical study.T...
Show More Status
Active Not Recruiting
Location
Shanghai Chest Hospital
Learn More & Join Trial
Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma PHASE1 In patients with locally advanced oral squamous cell carcinoma (OSCC), due ...
Show More Location
Shanghai Ninth People's Hospital
Learn More & Join Trial
An Umbrella-designed Prospective Multicenter Randomized Open-label Superiority Trial Evaluating Multi-biomarker-guided Precision Therapy for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma PHASE2 This is a prospective, multicenter, randomized, open-label, umbrella superi...
Show More Learn More & Join Trial
Oncolytic Virus in Esophageal Squamous Cell Carcinoma PHASE1 This clinical trial is designed to evaluate the preliminary efficacy and sa...
Show More Location
West China Hospital of Sichuan University
Learn More & Join Trial
A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold Regions N/A Hepatocellular carcinoma (HCC) is a common global malignancy. In China, the...
Show More Status
Active Not Recruiting
Location
Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin, Heilongjiang Province, China
Learn More & Join Trial
Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor Failure PHASE2 This prospective, single-arm trial explores the efficacy of Adibelimab mono...
Show More Location
Multiple Locations
Learn More & Join Trial